Stockholm - Delayed Quote SEK

Chordate Medical Holding AB (publ) (CMH.ST)

10.25
+1.13
+(12.39%)
At close: May 14 at 5:20:09 PM GMT+2
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
664.69
664.69
976.28
108.52
882.05
Cost of Revenue
-1,323.87
-1,323.87
-332.90
74.46
-1,043.12
Gross Profit
1,988.56
1,988.56
1,309.18
34.06
1,925.16
Operating Expense
29,433.76
29,433.76
30,880.76
28,058.18
23,666.55
Operating Income
-27,445.20
-27,445.20
-29,571.57
-28,024.12
-21,741.39
Net Non Operating Interest Income Expense
191.62
191.62
384.90
81.15
-24.89
Pretax Income
-27,253.58
-27,253.58
-29,186.68
-27,942.97
-21,766.28
Net Income Common Stockholders
-27,253.58
-27,253.58
-29,186.68
-27,942.97
-21,766.28
Diluted NI Available to Com Stockholders
-27,253.58
-27,253.58
-29,186.68
-27,942.97
-21,766.28
Basic EPS
-26.60
-26.60
-0.12
-65.03
-68.64
Diluted EPS
-26.60
-26.60
-0.12
-65.03
-68.64
Basic Average Shares
1,024.53
1,024.53
643.35
429.72
157,712.38
Diluted Average Shares
1,165.17
1,024.53
643.35
429.72
157,712.38
Total Operating Income as Reported
--
--
--
-28,024.12
-21,741.39
Total Expenses
28,109.88
28,109.88
30,547.85
28,132.64
22,623.44
Net Income from Continuing & Discontinued Operation
-27,253.58
-27,253.58
-29,186.68
-27,942.97
-21,766.28
Normalized Income
-27,253.58
-27,253.58
-29,186.68
-27,942.97
-21,766.28
Interest Income
191.62
191.62
384.90
81.15
--
Interest Expense
2.77
--
6.68
--
24.89
Net Interest Income
191.62
191.62
384.90
81.15
-24.89
EBIT
-27,445.20
-27,445.20
-29,571.57
-28,024.12
-21,741.39
EBITDA
-25,226.24
-25,226.24
-27,118.33
-25,570.88
-20,200.33
Reconciled Cost of Revenue
-1,323.87
-1,323.87
-332.90
74.46
-1,043.12
Reconciled Depreciation
2,218.96
2,218.96
2,453.24
2,453.24
1,541.06
Net Income from Continuing Operation Net Minority Interest
-27,253.58
-27,253.58
-29,186.68
-27,942.97
-21,766.28
Normalized EBITDA
-25,226.24
-25,226.24
-27,118.33
-25,570.88
-20,200.33
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/15/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers